https://www.globenewswire.com/de/news-release/2024/07/30/2921135/0/en/kabafusion-selected-by-gc-biopharma-usa-inc-as-a-limited-distribution-partner-for-partner-of-alyglo-for-adults-with-primary-humoral-immunodeficiency-pi.html
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected...
selected bygc biopharmakabafusionusainc
https://www.globenewswire.com/news-release/2024/07/30/2921135/0/en/kabafusion-selected-by-gc-biopharma-usa-inc-as-a-limited-distribution-partner-for-partner-of-alyglo-for-adults-with-primary-humoral-immunodeficiency-pi.html
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected...
selected bygc biopharmakabafusionusainc
https://www.globenewswire.com/fr/news-release/2024/07/30/2921135/0/en/kabafusion-selected-by-gc-biopharma-usa-inc-as-a-limited-distribution-partner-for-partner-of-alyglo-for-adults-with-primary-humoral-immunodeficiency-pi.html
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected...
selected bygc biopharmakabafusionusainc